Coeptis Therapeutics (NASDAQ:COEP) Stock Price Up 0.3% - Here's Why
I'm PortAI, I can summarize articles.
Coeptis Therapeutics (NASDAQ:COEP) saw a 0.3% increase in stock price, trading at $15.04 after reaching a high of $15.28. Trading volume was down 72% from the average, with 12,602 shares exchanged. Analysts maintain a consensus "Sell" rating, with Weiss Ratings reiterating a "sell (e+)" rating. The company reported a quarterly EPS of ($1.17) and revenue of $0.20 million. Coeptis focuses on developing cell therapy platforms for cancer treatment, with a market cap of $72.49 million and a debt-to-equity ratio of 0.02.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments